Mor, S. (2022) “Synthesis, Type II diabetes inhibitory activity, antimicrobial evaluation, and docking studies of N’-arylidene-2-((7-methylbenzo[4,5]thiazolo[2,3-c] [1,2,4]triazol-3-yl)thio)acetohydrazides”, European Journal of Chemistry, 13(4), pp. 426–434. doi: 10.5155/eurjchem.13.4.426-434.2315.